CNMD vs SN.L
CNMD: CONMED is a global medical technology company specializing in innovative surgical devices and equipment for minimally invasive procedures. SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions.
Side-by-side fundamentals
| Metric | CNMD | SN.L | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $49.30 | £11.97 | |
| Market cap as of 2026-08-06 | $1.5B | n/a | |
| P/E as of 2026-08-06 | 26.20 | n/a | |
| Net margin as of 2026-08-06 | +4.1% | n/a | |
| Gross margin as of 2026-08-06 | +55.8% | n/a | |
| Operating margin as of 2026-08-06 | +8.0% | n/a | |
| ROE as of 2026-08-06 | +5.5% | n/a | |
| ROA as of 2026-08-06 | +2.4% | n/a | |
| Debt / equity as of 2026-08-06 | 0.80 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +3.4% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +9.6% | n/a | |
| Dividend yield as of 2026-08-06 | +1.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-08-06 | 0.95 | n/a | |
| 1-year return as of 2026-08-05 close | -7.9% | +3.5% | SN.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.